Verition Fund Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.18M | Sell |
10,336
-11,126
| -52% | -$5.34M | 0.03% | 638 |
|
|
2026
Q1 | $10.5M | Buy |
21,462
+4,099
| +24% | +$2.22M | 0.07% | 307 |
|
|
2025
Q4 | $10.1M | Buy |
17,363
+8,074
| +87% | +$4.57M | 0.04% | 447 |
|
|
2025
Q3 | $4.51M | Sell |
9,289
-26,252
| -74% | -$12.2M | 0.02% | 1259 |
|
|
2025
Q2 | $14.4M | Buy |
35,541
+1,902
| +6% | +$795K | 0.06% | 348 |
|
|
2025
Q1 | $16.7M | Buy |
33,639
+7,103
| +27% | +$3.85M | 0.08% | 279 |
|
|
2024
Q4 | $13.8M | Buy |
26,536
+19,699
| +288% | +$10.8M | 0.05% | 376 |
|
|
2024
Q3 | $4.23M | Sell |
6,837
-10,788
| -61% | -$6.39M | 0.02% | 971 |
|
|
2024
Q2 | $9.75M | Sell |
17,625
-4,933
| -22% | -$2.83M | 0.05% | 361 |
|
|
2024
Q1 | $13.1M | Buy |
22,558
+7,986
| +55% | +$4.48M | 0.09% | 223 |
|
|
2023
Q4 | $7.73M | Sell |
14,572
-4,681
| -24% | -$2.27M | 0.06% | 308 |
|
|
2023
Q3 | $9.75M | Buy |
19,253
+12,161
| +171% | +$6.48M | 0.11% | 225 |
|
|
2023
Q2 | $3.7M | Buy |
7,092
+6,476
| +1,051% | +$3.49M | 0.05% | 442 |
|
|
2023
Q1 | $355K | Sell |
616
-1,346
| -69% | -$759K | ﹤0.01% | 1419 |
|
|
2022
Q4 | $1.08M | Sell |
1,962
-734
| -27% | -$389K | 0.02% | 881 |
|
|
2022
Q3 | $1.37M | Buy |
2,696
+1,003
| +59% | +$561K | 0.02% | 1170 |
|
|
2022
Q2 | $920K | Buy |
+1,693
| New | +$932K | 0.02% | 1076 |
|
|
2022
Q1 | – | Sell |
-965
| Closed | -$554K | – | 3035 |
|
|
2021
Q4 | $644K | Buy |
+965
| New | +$603K | ﹤0.01% | 1564 |
|
|
2021
Q3 | – | Sell |
-2,684
| Closed | -$1.35M | – | 2310 |
|
|
2021
Q2 | $1.35M | Buy |
2,684
+1,512
| +129% | +$713K | 0.01% | 678 |
|
|
2021
Q1 | $535K | Buy |
+1,172
| New | +$559K | 0.01% | 834 |
|
|
2020
Q1 | – | Sell |
-4,881
| Closed | -$1.59M | – | 1051 |
|
|
2019
Q4 | $1.59M | Buy |
+4,881
| New | +$1.48M | 0.03% | 327 |
|
|
2018
Q3 | – | Sell |
-1,258
| Closed | -$261K | – | 1443 |
|
|
2018
Q2 | $261K | Sell |
1,258
-1,136
| -47% | -$241K | 0.02% | 913 |
|
|
2018
Q1 | $494K | Buy |
+2,394
| New | +$502K | 0.04% | 638 |
|
|
2017
Q3 | – | Sell |
-14,668
| Closed | -$2.56M | – | 1371 |
|
|
2017
Q2 | $2.56M | Sell |
14,668
-9,960
| -40% | -$1.67M | 0.25% | 69 |
|
|
2017
Q1 | $3.78M | Buy |
24,628
+8,069
| +49% | +$1.23M | 0.35% | 37 |
|
|
2016
Q4 | $2.34M | Buy |
+16,559
| New | +$2.44M | 0.2% | 88 |
|
|
2015
Q1 | – | Sell |
-1,971
| Closed | -$247K | – | 497 |
|
|
2014
Q4 | $247K | Sell |
1,971
-6,855
| -78% | -$834K | 0.06% | 180 |
|
|
2014
Q3 | $1.07M | Buy |
8,826
+1,403
| +19% | +$171K | 0.15% | 105 |
|
|
2014
Q2 | $876K | Buy |
+7,423
| New | +$874K | 0.09% | 134 |
|
|
2013
Q3 | – | Sell |
-3,468
| Closed | -$293K | – | 687 |
|
|
2013
Q2 | $293K | Buy |
+3,468
| New | +$289K | 0.05% | 360 |
|
Other funds holding TMO
Verition Fund Management's TMO Position: Q2 2026 in Review
Verition Fund Management reduced its Thermo Fisher Scientific (TMO) stake by 52% in Q2 2026, selling an estimated $5.34M and leaving 10,336 shares worth $5.18M. The position accounts for 0.03% of the portfolio, ranked #638.
Verition Fund Management first reported a position in TMO in Q2 2013 and has held it in 30 quarters since. The position peaked at $16.7M in Q1 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Verition Fund Management held 10,336 shares of Thermo Fisher Scientific worth $5.18M as of Q2 2026.
- Verition Fund Management sold 11,126 Thermo Fisher Scientific shares in Q2 2026, an estimated $5.34M.
- Thermo Fisher Scientific made up 0.03% of Verition Fund Management's portfolio in Q2 2026, its #638 holding.
- Verition Fund Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 30 quarters since.
- Verition Fund Management's Thermo Fisher Scientific position peaked at $16.7M in Q1 2025.
- 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Verition Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.